Business Development
If developing new drugs is about Research and Development, finding new business opportunities for Shire is about ‘Search and Development’.
One of the keys to Shire’s success so far has been the shrewd use of strategic partnerships and alliances, and an astute approach to licensing and acquisitions. Our Business Development team actively explore all the new opportunities open to us, and teams from across the company work together to decide which business model is the most appropriate to exploit it.
The Corporate Development team will help Shire realize its goals by supporting Shire’s continued growth and evolution to a patient centric company focused on the development and commercialization of highly value-added therapeutics for the treatment of diseases with high unmet need in specialty, regenerative medicine and rare disease markets.
In driving our mission, the Corporate Development team will seek to identify and create highly innovative solutions to drive Shire’s continued growth and success. We will constantly monitor new technologies and products in our therapeutic areas of current interest and identify new areas for expansion of the Shire business model.
In attaining our mission, Shire will be viewed as the partner of choice by all new and current stakeholders including patients, payors, physicians and policy makers.
Related links
Learn more about the interaction with our contractors and suppliers:
Did you know...?
We were founded in the UK in 1986 and have built our business through a number of strategic
acquisitions and
licensing transactions.
